- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
October 7, 2008
INDIANAPOLIS — Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co. Indianapols-based Lilly announced....